Clinical Trials on Immune Response in New Zealand
Total 8608 results
-
Society for Applied StudiesNorwegian Institute of Public Health; Christian Medical College, Vellore, IndiaCompletedInnate Immune ResponseIndia
-
Alexion PharmaceuticalsSyneos HealthTerminated
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Resistentia Pharmaceuticals ABCompleted
-
Brock UniversityCompletedInflammatory Response | Sports PerformanceCanada
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Tandem Diabetes Care, Inc.Recruiting
-
Insulet CorporationCompleted
-
University of OtagoCompleted
-
Tavotek BiotherapeuticsRecruiting
-
Diatranz Otsuka LimitedCompleted
-
Edgar National Centre for Diabetes ResearchCompletedInsulin ResistanceNew Zealand
-
Gilead SciencesCompletedHIVUnited States, New Zealand
-
Arrowhead PharmaceuticalsRecruitingIgA NephropathyNew Zealand
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
GlaxoSmithKlineCompleted
-
University of British ColumbiaCompleted
-
Rijnstate HospitalWithdrawnInflammatory Response | Abdominal Aortic AneurysmNew Zealand, Netherlands, Spain, Germany, Poland
-
GlaxoSmithKlineCompleted
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
Australian and New Zealand Intensive Care Research...Melbourne Health; The Alfred; Barwon Health; Wellington Hospital; Monash Health; Austin... and other collaboratorsCompletedSepsis | Shock, Septic | Critically Ill | Vasoplegic SyndromeAustralia, New Zealand, Brazil
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Zenas BioPharma (USA), LLCActive, not recruitingRheumatoid Arthritis | Healthy VolunteersNew Zealand, Australia
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
Rutgers, The State University of New JerseyCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
University of Medicine and Dentistry of New JerseyCompletedPeripheral Vascular ResponseUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedAsthmaUnited Kingdom, New Zealand
-
AstraZenecaCompletedAsthmaNew Zealand, United Kingdom
-
NYU Langone HealthRecruiting
-
DSM Nutritional Products, Inc.Completed
-
University of Auckland, New ZealandCounties Manukau Health; Auckland Medical Research Foundation; Auckland District... and other collaboratorsUnknown
-
Hospital for Special Surgery, New YorkCompleted
-
NYU Langone HealthTerminatedInflammatory ResponseUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
GlaxoSmithKlineCompletedAsthmaSweden, Australia, New Zealand
-
GlaxoSmithKlineCompletedAsthmaNew Zealand, South Africa
-
GlaxoSmithKlineCompletedAsthmaUnited Kingdom, Germany, New Zealand
-
CSL LimitedCompletedPrimary Immune DeficiencyAustralia, New Zealand
-
James Cook University, Queensland, AustraliaNational Health and Medical Research Council, Australia; The Prince Charles... and other collaboratorsCompleted
-
Ribon Therapeutics, Inc.RecruitingAtopic DermatitisAustralia, New Zealand
-
Regeneron PharmaceuticalsCompletedAllergyUnited Kingdom, New Zealand, Netherlands, Sweden
-
Theravance BiopharmaGlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveThailand, New Zealand, United Kingdom